Yohan Liyanage > Linklaters LLP > London, England > Lawyer Profile
Linklaters LLP Offices

ONE SILK STREET
LONDON
EC2Y 8HQ
England
- Firm Profile
- Go to...
Yohan Liyanage

Work Department
Intellectual property
Position
Advises on a broad range of contentious and non-contentious IP projects, including UK and multi-jurisdictional patent litigation, IP licences and commercialisation arrangements, and the IP aspects of cross-border M&A, joint ventures and IPOs.
Career
Trained at Linklaters; Associate Linklaters 2003-2007; Associate Taylor Wessing 2007-2010; Managing Associate Linklaters 2010-2012; Counsel 2012-2017; Partner in 2017.
Memberships
AIPPI UK; member of the editorial board of BioScience Law Review.
Education
Corpus Christi College, Cambridge (BA (Hons) First Class Biochemistry); Magdalen College, Oxford (D. Phil. Neuroscience).
Leisure
Music; travel.
Lawyer Rankings
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
The ‘extremely diligent and creative’ team at Linklaters LLP is positioned at the crux of multiple sectors and is able to advise across these, utilising its varied experience that is comprised of contentious and non-contentious mandates for pharmaceutical and biotech companies. The practice is jointly helmed by four key players: Ian Karet, who possesses more than 30 years of experience in the field, Yohan Liyanage, who is notably well-versed in the technology space, the ‘extremely good patent litigator’ Katie Coltart, who brought her expertise in biologics and biosimilars from Kirkland & Ellis International LLP in October 2023, and Paul Joseph, whose litany of experience extends from technology patent litigation to joint venture agreements. Stephanie Farrington principally focuses on the healthcare and life sciences sector.
London > TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
Ian Karet, Yohan Liyanage, Paul Joseph, and Katie Coltart lead the team at Linklaters LLP, which has handled some notable trade mark litigation and IP licensing arrangements. Karet is active in the industries of pharmaceuticals and technology, and Liyanage is routinely engaged by clients for assistance with licensing and commercialisation arrangements. Joseph’s wide-ranging capabilities are comprised of copyright disputes, commercialisation, and IP structuring mandates, among others. Coltart joined from Kirkland & Ellis International LLP in October 2023. Jennifer Heley is another key name to note with her transactional strengths.
London > Industry focus > Life sciences and healthcare
Praised for its ability to provide creative solutions tailored to bespoke situations, Linklaters LLP assists a litany of major pharmaceutical, biotech, digital health and medical device companies with work including transactions, patent and trade mark litigations and licensing disputes. Marly Didizian, described as ‘first choice for the tricky stuff’, co-heads the team and is noted on the market for her ability to handle high-profile pharma mergers and carve-outs. Fellow co-head Aisling Zarraga is equipped to handle matters spanning M&A, joint ventures and corporate governance advisory work. IP expert Yohan Liyanage assists clients with IP transactions and patent litigation. Trade mark and patent disputes are staples of Ian Karet‘s far-reaching practice. Katie Coltart has a proven track record in coordinating cross-border patent litigation.
Lawyer Rankings
- Life sciences and healthcare London > Industry focus
- Intellectual property: patents (contentious and non-contentious) London > TMT (technology, media and telecoms)
- Intellectual property: trade marks, copyright and design London > TMT (technology, media and telecoms)
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Bank lending: investment grade debt and syndicated loans
- Dispute resolution > Banking litigation: investment and retail
- Finance > Corporate restructuring & insolvency
- Risk advisory > Data protection, privacy and cybersecurity
- Finance > Debt capital markets
- Finance > Derivatives and structured products
- Industry focus > Emerging markets
- Employment > Employee share schemes
- Employment > Employers
- Real estate > Environment
- Corporate and commercial > Equity capital markets: mid-large cap
- Risk advisory > ESG
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: contentious
- Corporate and commercial > Financial services: non-contentious/regulatory
- TMT (technology, media and telecoms) > Fintech: corporate and commercial
- TMT (technology, media and telecoms) > Fintech: regulatory
- Finance > Debt capital markets
- Finance > Debt capital markets
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- Projects, energy and natural resources > Infrastructure: Project finance and development
- TMT (technology, media and telecoms) > IT and telecoms
- Real estate > Commercial property: corporate occupiers
- Finance > Debt capital markets
- Finance > Debt capital markets
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Projects, energy and natural resources > Mining and minerals
- Finance > Debt capital markets
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Projects, energy and natural resources > Power (including electricity and nuclear)
- Transport > Rail
- Investment fund formation and management > Real estate funds
- Projects, energy and natural resources > Renewables
- Finance > Securitisation
- Projects, energy and natural resources > Water
Firm Rankings
- Corporate and commercial > Commercial contracts
- Dispute resolution > Commercial litigation: premium
- Real estate > Commercial property: investment
- Dispute resolution > Competition litigation
- Risk advisory > Corporate governance
- Corporate and commercial > Corporate tax
- Finance > High yield
- Industry focus > Life sciences and healthcare
- Projects, energy and natural resources > Oil and gas
- Corporate and commercial > Private equity: transactions – high-value deals (£500m+)
- Investment fund formation and management > Private funds
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Public sector > Administrative and public law
- Real estate > Commercial property: development
- Real estate > Construction: non-contentious
- Insurance > Insurance: corporate and regulatory
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Dispute resolution > International arbitration
- Dispute resolution > Public international law
- Industry focus > Retail and consumer
- Finance > Trade finance
- Real estate > Commercial property: corporate occupiers
- Crime, fraud and licensing > Fraud: civil
- Investment fund formation and management > Fund finance
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Finance > Transport finance and leasing
- TMT (technology, media and telecoms) > Sport